
Researchers at the University of Cambridge have discovered how reading affects cognitive abilities at different ages.
Regular reading for pleasure is associated with a slower decline in cognitive abilities and a lower risk of dementia in old age, scientists at the University of Cambridge have found.
AI-generated summary
Researchers at the University of Cambridge have summarized previous work on the effects of reading on cognitive function.
Regular reading for pleasure may be associated with slower cognitive decline and a lower risk of dementia in later life. Researchers at the University of Cambridge came to this conclusion by summarizing data from previous studies. The review was published in the journal Psychological Medicine (PM).
Research shows that the benefits of reading begin in childhood. An analysis of data from more than 10,000 young people showed that children who started reading for pleasure early were better able to cope with memory, attention and executive function tasks, were more successful in school and were less likely to experience mental health problems.
Positive effects were also found in adults. Reading has been linked to reduced stress, improved concentration, and greater empathy. In one study, just five minutes of reading fiction reduced stress levels by up to 20 percent.
The benefits may be especially noticeable in old age. In a study of nearly 5,500 people over 55, those who regularly engaged in brain-stimulating activities, including reading, were less likely to experience cognitive impairment over the next five years. Other work linked reading books, newspapers and magazines to a 33 percent reduction in the risk of Alzheimer's disease.
Scientists suggest that reading continually engages memory, language, attention, and other cognitive functions. However, the authors emphasize that most of the existing research shows a connection, and does not prove that reading directly prevents dementia.

Uganda successfully dealt with the Ebola outbreak with the assistance of Russian specialists, said the head of Rospotrebnadzor Anna Popova at a meeting with Russian President Vladimir Putin.

Russian schoolchildren are massively taking the antiviral drug Rimantadine due to a trend on TikTok for the sake of hallucinations. Narcologists warn about the danger of the drug for the central nervous system.

Director of the Gamaleya Research Center for Epidemiology and Medicine, Denis Logunov, announced the administration of the Russian antitumor vaccine against melanoma to two patients.

Influenza vaccines with a completely updated composition have begun to arrive in Russian regions, replacing all three strains compared to the last epidemic season.

Ruskin oncologist Justin Stebbing said the bacterium Helicobacter pylori can increase the risk of developing bowel cancer by about 1.6 times, although it is not the main cause.

The company "PSK Pharma" received a registration certificate for "Bosentan PSK" - the first Russian generic drug for the treatment of pulmonary arterial hypertension in patients from three months of age.